Recursion Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Recursion Pharmaceuticals has a total of 149 patents globally, out of which 58 have been granted. Of these 149 patents, more than 78% patents are active. United States of America is where Recursion Pharmaceuticals has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Recursion.

Recursion Pharmaceuticals was founded in the year 2013. The Company researches, discovers and develops pharmaceuticals. It focuses on the interaction of known bioactive compounds and hereditary diseases.

Do read about some of the most popular patents of Recursion which have been covered by us in this article and also you can find Recursion patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Recursion patent portfolio.

How many patents does the founder and the CEO of Recursion Pharmaceuticals have?

The founders Blake Borgeson has 10 patents and Dean Li has 0 patent and CEO Chris Gibson has 5 patents.

How many patents does Recursion Pharmaceuticals have?

Recursion has a total of 149 patents globally. These patents belong to 73 unique patent families. Out of 149 patents, 117 patents are active.

How Many Patents did Recursion Pharmaceuticals File Every Year?

Recursion Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRecursion Applications FiledRecursion Patents Granted
202324
202295
2021275
20202010
20192218
20181311
2017154
2016211
201519
20141

How many Recursion Pharmaceuticals patents are Alive/Dead?

Recursion Patent Portfolio

 How Many Patents did Recursion Pharmaceuticals File in Different Countries?

Recursion Worldwide Patent Filing

Countries in which Recursion Pharmaceuticals Filed Patents

CountryPatents
United States Of America88
Europe12
Canada8
Israel5
China4
Hong Kong (S.A.R.)3
Australia2
Germany2
Singapore2
Japan1
Taiwan1
New Zealand1

Where are Research Centres of Recursion Pharmaceuticals Patents Located?

The Research Centre for all the Recursion Pharmaceuticals patents is the United States of America.

10 Best Recursion Pharmaceuticals Patents

US9671276B1 is the most popular patent in the Recursion Pharmaceuticals portfolio. It has received 16 citations so far from companies like Ways, Inc, Robert Bosch and Sharp Kabushiki Kaisha.

Below is the list of 10 most cited patents of Recursion Pharmaceuticals:

Publication NumberCitation Count
US9671276B116
US9485966B112
US20170000081A111
US10146914B110
US10292369B19
US20190037800A19
US10064392B17
US9578853B17
US20190183089A17
US9986716B16

What Percentage of Recursion Pharmaceuticals US Patent Applications were Granted?

Recursion Pharmaceuticals (Excluding its subsidiaries) has filed 71 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 47 have been granted leading to a grant rate of 83.93%.

Below are the key stats of Recursion patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Recursion Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Kim Rubin Patent Agent4680.00%
Morris Patent Law15100.00%
Nienstadt5100.00%
Artegis Law Group3100.00%
Banner & Witcoff10%
Patent Docket Department10%

What are Recursion Pharmaceuticals’ key innovation segments?

What Technologies are Covered by Recursion Pharmaceuticals?

The chart below distributes patents filed by Recursion Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Recursion Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Recursion Pharmaceuticals’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Recursion Pharmaceuticals?

Table of Content

Insights you may find interesting

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.